Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 29 / 2024
Date of issue: 2024-07-01
Short name of the issuer
KRKA
Subject
KRKA, d. d., Novo mesto Decision by the European Commission regarding perindopril
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
According to Article 17 of Regulation (EU) No 596/2014, company Krka, d. d., Novo mesto hereby informs the interested public that it has received the judgement of the Court of Justice of the EU (CJEU) in the perindopril case.

The European Commission decided in 2014 that Krka had allegedly breached Article 101 of the Treaty on the Functioning of the European Union and caused a distortion on the perindopril market in the EU, and imposed on Krka a fine in the amount of EUR 10,000,000. Krka has paid the fine.

Krka filed a claim against the decision at General Court of the EU in 2014 (General Court).

The General Court decided in favour of Krka in December 2018, it found that Krka had not distorted competition and had not breached Article 101 of the Treaty on the Functioning of the European Union.

The Commission filed appeal against the decision of the General Court at the Court of Justice of the EU, consequently Krka formed provisions in the amount of EUR 10,000,000.

On 27 June 2024, the Court of Justice of the EU ruled on the Commission's appeal against the decision of the General Court. The Court of Justice of the EU upheld the Commission's appeal and returned the case to the General Court of the EU for reconsideration.

Krka published the announcements considering the investigation on 26 November 2008, 6 January 2009, 8 July 2009, 3 July 2014, 9 July 2014 and 12 December 2018.

The notice will be published on the Company's website (www.krka.biz) from 1 July 2024 onwards, for a period of at least 5 years.
Annexes
File Description

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-07-01 Jože Colarič
 President of the Management Board and CEO